Regression analysis of topological indices for predicting efficacy of Alzheimer's drugs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39485746.
- Also identified by DOI 10.1371/journal.pone.0309477 and PMC identifier 11530053.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alzheimer's Disease(AD) is the most common type of dementia. It is a progressive disease beginning with mild memory loss and possibly leading to loss of the ability to carry on a conversation and respond to the environment. This study investigates the relationship between the chemical structure of potential AD drugs and their therapeutic efficacy using Multi-Criteria Decision-Making (MCDM) techniques including The approach for Order Preference by Similarity to Ideal Solution (TOPSIS) and Simple Additive Weighting (SAW) method. A comprehensive dataset comprising molecular descriptors and corresponding pharmacological properties, i.e., melting point, boiling point, molecular weight and density of AD drugs was compiled from diverse sources. Topological indices were calculated to capture the structural characteristics of these compounds. Application of TOPSIS and SAW through Entropy method helps obtain optimal drugs for curing AD. Quantitative Structure Property Relationships (QSPR) analysis has been done between properties and topological indices of AD's drug structures. Results revealed significant relations between specific topological indices and drug efficacy, providing insights into the structural features crucial for AD treatment efficacy. This approach offers a promising avenue for rational drug design and optimization in the quest for novel AD therapeutics.
Medical subject headings
- Alzheimer Disease